XML 29 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Operations (USD $)
 12 Months Ended 125 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Statement Consolidated Statements Of Operations [Line Items]      
REVENUE $ 290,266 $ 146,875 $ 4,429,100
OPERATING EXPENSES      
Salaries and payroll-related expenses 6,667,669 6,414,921 33,059,799
General and administrative expenses 3,488,864 6,439,323 34,842,079
Research and development 8,705,627 5,391,463 51,324,375
Stock-based compensation 1,536,271 1,241,404 15,117,739
Depreciation and amortization 1,751,412 1,748,975 9,160,698
Impairment expense 1,308,047   1,308,047
Contingent consideration – fair value adjustments 1,421,652   1,421,652
TOTAL OPERATING EXPENSES 24,879,542 21,236,086 146,234,389
OPERATING LOSS (24,589,276) (21,089,211) (141,805,289)
OTHER INCOME (EXPENSE)      
Equity in income (loss) of unconsolidated affiliates (641,141) (240,154) (1,604,548)
Impairment of investment in unconsolidated affiliates   (1,642,775) (1,642,775)
Gain on purchase of Roche Madison   1,576,107 1,576,107
Gain (loss) on sale of fixed assets, net (76,388) (1,079,377) (1,282,853)
Realized and unrealized gain (loss) in marketable securities   (58,091) 62,954
Interest income (expense), net (97,910) 35,966 2,652,534
Change in value of derivatives (5,300,389) 386,892 (2,018,985)
Gain on sale of stock in subsidiary     2,292,800
Other income (expense) (997,975)   (747,975)
TOTAL OTHER INCOME (EXPENSE) (7,113,803) (1,021,432) (712,741)
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES (31,703,079) (22,110,643) (142,518,030)
Provision for income taxes         
LOSS FROM CONTINUING OPERATIONS (31,703,079) (22,110,643) (142,518,030)
Loss from discontinued operations (354) (80) (47,546,996)
Gain on disposal of discontinued operations     4,708,588
NET LOSS FROM DISCONTINUED OPERATIONS (354) (80) (42,838,408)
NET LOSS (31,703,433) (22,110,723) (185,356,438)
Net loss attributable to noncontrolling interests 560,144 984,795 19,379,429
NET LOSS ATTRIBUTABLE TO ARROWHEAD $ (31,143,289) $ (21,125,928) $ (165,977,009)
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS — BASIC & DILUTED: $ (1.30) $ (1.90)  
Weighted average shares outstanding — basic and diluted 24,002,224 11,129,766